ID: h-debate-ffb8f8a629e2
Hypothesis

IGFBPL1-Mediated Microglial Homeostasis Reset Therapy

Targeted delivery of IGFBPL1 or its functional mimetics could serve as a master switch to restore microglial homeostasis in preclinical AD.
🧬 IGFBPL1🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

Targeted delivery of IGFBPL1 or its functional mimetics could serve as a master switch to restore microglial homeostasis in preclinical AD. This approach would leverage IGFBPL1's dual role in maintaining surveillance state and resolving existing neuroinflammation before tau pathology spreads.

Debate provenance: derived from debate `sess_SDA-2026-04-04-gap-20260404-microglial-priming-early-ad` on question: Investigate mechanistic links between early microglial priming states, neuroinflammatory signaling, and downstream neurodegeneration in preclinical and prodromal AD.. Consensus signal: skeptic, synthesizer, theorist discussed the mechanism terms Homeostasis, IGFBPL1, IGFBPL1-Mediated, Microglial, Reset, microglial, neuroinflammation. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for IGFBPL1

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    h_d4ff5555["h-d4ff5555"] -->|targets| IGFBPL1["IGFBPL1"]
    IGFBPL1_1["IGFBPL1"] -.->|inhibits| neuroinflammation["neuroinflammation"]
    IGFBPL1_2["IGFBPL1"] -->|prevents| tau_pathology["tau_pathology"]
    IGFBPL1_3["IGFBPL1"] -->|prevents| neuroinflammation_4["neuroinflammation"]
    IGFBPL1_5["IGFBPL1"] -->|regulates| microglial_homeostasis["microglial_homeostasis"]
    IGFBPL1_6["IGFBPL1"] -->|associated with mi| Alzheimer_s_disease["Alzheimer's disease"]
    IGFBPL1_7["IGFBPL1"] -->|associated with| neurodegeneration["neurodegeneration"]
    C1QA__C3__CX3CR1__CX3CL1["C1QA, C3, CX3CR1, CX3CL1"] -->|co associated with| IGFBPL1_8["IGFBPL1"]
    CLOCK__ARNTL["CLOCK, ARNTL"] -->|co associated with| IGFBPL1_9["IGFBPL1"]
    GPR43__GPR109A["GPR43, GPR109A"] -->|co associated with| IGFBPL1_10["IGFBPL1"]
    HIF1A__NFKB1["HIF1A, NFKB1"] -->|co associated with| IGFBPL1_11["IGFBPL1"]
    APOE["APOE"] -->|co associated with| IGFBPL1_12["IGFBPL1"]
    IGFBPL1_13["IGFBPL1"] -->|co associated with| TNF_IL6["TNF/IL6"]
    IGFBPL1_14["IGFBPL1"] -->|co associated with| Multiple["Multiple"]
    IGFBPL1_15["IGFBPL1"] -->|co associated with| TREM2["TREM2"]
    style h_d4ff5555 fill:#4fc3f7,stroke:#333,color:#000
    style IGFBPL1 fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_1 fill:#ce93d8,stroke:#333,color:#000
    style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
    style IGFBPL1_2 fill:#ce93d8,stroke:#333,color:#000
    style tau_pathology fill:#4fc3f7,stroke:#333,color:#000
    style IGFBPL1_3 fill:#ce93d8,stroke:#333,color:#000
    style neuroinflammation_4 fill:#4fc3f7,stroke:#333,color:#000
    style IGFBPL1_5 fill:#ce93d8,stroke:#333,color:#000
    style microglial_homeostasis fill:#4fc3f7,stroke:#333,color:#000
    style IGFBPL1_6 fill:#ce93d8,stroke:#333,color:#000
    style Alzheimer_s_disease fill:#ef5350,stroke:#333,color:#000
    style IGFBPL1_7 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style C1QA__C3__CX3CR1__CX3CL1 fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_8 fill:#ce93d8,stroke:#333,color:#000
    style CLOCK__ARNTL fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_9 fill:#ce93d8,stroke:#333,color:#000
    style GPR43__GPR109A fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_10 fill:#ce93d8,stroke:#333,color:#000
    style HIF1A__NFKB1 fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_11 fill:#ce93d8,stroke:#333,color:#000
    style APOE fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_12 fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_13 fill:#ce93d8,stroke:#333,color:#000
    style TNF_IL6 fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_14 fill:#ce93d8,stroke:#333,color:#000
    style Multiple fill:#ce93d8,stroke:#333,color:#000
    style IGFBPL1_15 fill:#ce93d8,stroke:#333,color:#000
    style TREM2 fill:#ce93d8,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — IGFBPL1

No curated PDB or AlphaFold mapping for IGFBPL1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for IGFBPL1 →

No DepMap CRISPR Chronos data found for IGFBPL1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
30,310
$0.1590
Total Cost
$0.1590
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.